Sign inJoin waitlistJoin the waitlist

MI

Matthew Ingham

Clinical Associate Professor · NYU Grossman School of Medicine

Credentials: · · ·

History

NYU Grossman School of Medicine
Present

New York Presbyterian Hospital
2014–2017
Internal Medicine
NYU Grossman School of Medicine
2011–2013
University of Massachusetts T.H. Chan School of Medicine
2006–2010

Research

Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas
Clinical Cancer Research · 2022 · 339 citations
Cell-Cycle Therapeutics Come of Age
Review · Journal of Clinical Oncology · 2017 · First of 2 authors · 277 citations
Dissecting the treatment-naive ecosystem of human melanoma brain metastasis
Cell · 2022 · 172 citations

Gary Schwartz
18 papers
BT
Brian Van Tine
7 papers
Sminu Bose
5 papers
Christian Meyer
3 papers
JO
Jay Oza
3 papers · 1 as a fellow
Jonathan Trent
3 papers
Sahil Doshi
3 papers
Steven Attia
3 papers
Archana Ajmera
2 papers
Armando Del Portillo
2 papers
Benjamin Izar
2 papers
Blake Caldwell
2 papers · 2 as a fellow

Clinical trials

Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma
Principal investigator · Withdrawn · Phase 1
Matthew Ingham
2020
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
Principal investigator · Completed · Phase 1, Phase 2
Intensity Therapeutics, Inc.
2017–2023